The appearance of tumor-specific Tn and STn antigens occurs in more than 80% of human carcinomas, and in all cases, detection of the STn antigen correlates with poor prognosis and decreased overall survival [10,11]. This evidence concerns the gene EEF1A2 and carcinoma.